miR-486 functions as a tumor suppressor in esophageal cancer by targeting CDK4/BCAS2
Article in Oncology Reports (November 2017)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Anti-tumor efficacy of theliatinib in esophageal cancer patient-derived xenografts models with epidermal growth factor receptor (EGFR) overexpression and gene amplification
Article in Oncotarget (April 2017)
Evolutionary history of phosphatidylinositol- 3-kinases: ancestral origin in eukaryotes and complex duplication patterns
Article in BMC Ecology and Evolution (October 2015)